Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Neurodevelopmental copy-number variants increase risk of internalizing and cardiometabolic multimorbidity: Findings from the UK Biobank

Katzourou, Ioanna K., LINC consortium, Barroso, Inês, Clayton, Julie, Khandaker, Golam, Stow, Daniel, Timpson, Nicolas, Tsang, Ruby, Underwood, Jack ORCID: https://orcid.org/0000-0003-1731-6039, Wood, Megan, Kirov, George ORCID: https://orcid.org/0000-0002-3427-3950, Walters, James ORCID: https://orcid.org/0000-0002-6980-4053, Owen, Michael J. ORCID: https://orcid.org/0000-0003-4798-0862, Holmans, Peter ORCID: https://orcid.org/0000-0003-0870-9412 and van den Bree, Marianne ORCID: https://orcid.org/0000-0002-4426-3254 2026. Neurodevelopmental copy-number variants increase risk of internalizing and cardiometabolic multimorbidity: Findings from the UK Biobank. American Journal of Human Genetics 113 (6) , pp. 1319-1329. 10.1016/j.ajhg.2026.02.021

[thumbnail of 1-s2.0-S0002929726001072-main.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (800kB) | Preview
License URL: http://creativecommons.org/licenses/by/4.0/
License Start date: 6 April 2026

Abstract

Internalizing and cardiometabolic multimorbidity (ICM-MM) represents a major clinical challenge, negatively impacting life expectancy and quality of life and resulting in considerable healthcare costs. Individuals with a copy-number variant associated with increased risk of neurodevelopmental conditions (ND-CNV) are more likely to develop mental or physical ill health; however, the effects on ICM-MM remain poorly understood. We used data from the UK Biobank (ND-CNV N = 7,549, 1.62%) to examine the effect of ND-CNVs on ICM-MM. ICM-MM was defined as a combination of any internalizing condition (depression, anxiety, or somatic symptom disorder) with each of five cardiometabolic conditions (hypertension, dyslipidemia, obesity, type 2 diabetes (T2D), and chronic kidney disease). We also studied whether ICM-MM risk in those with ND-CNVs differed by sex or presence of a deletion versus a duplication. We established associations between dosage-sensitive genes within ND-CNVs and ICM-MM and explored the interaction between the presence of ND-CNVs and polygenic risk scores (PRSs) of internalizing and cardiometabolic traits on ICM-MM risk. The presence of ND-CNVs was associated with ICM-MM (odds ratio [OR] range: 1.21–1.57). Female participants with ND-CNVs were more likely to have any internalizing condition and T2D, and those with a deletion were more likely to have any internalizing condition and obesity. The number of deleted haploinsufficient genes, but not duplicated triplosensitive genes, was associated with ICM-MM. No interactions between ND-CNVs and PRSs were found. We find that ND-CNVs increase the likelihood of ICM-MM, with evidence of sex differences and stronger effects for deletions. Increased clinical awareness can help ameliorate this risk.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Medicine
Schools > Psychology
Publisher: Cell Press
ISSN: 0002-9297
Funders: Medical Research Council
Projects: MR/W014416/1
Date of First Compliant Deposit: 13 April 2026
Date of Acceptance: 26 February 2026
Last Modified: 12 Aug 2026 09:58
URI: https://orca.cardiff.ac.uk/id/eprint/186336

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics